Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients

Claudio Coco, Gian Franco Zannoni, Alessandro Sgambato, Emanuele Caredda, Stefano Sioletic, Alma Boninsegna Lucarelli, Giannicola Genovese, Egidio Stigliano, Achille Renato Maria Cittadini, Mario Migaldi, Luca Reggiani Bonetti

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Expression levels of CD133, a cancer stem cell marker, and of the α-subunit of the dystroglycan (α-DG) complex, have been previously reported to be altered in colorectal cancers.
Original languageEnglish
Pages (from-to)71-71
Number of pages1
JournalJOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume31
DOIs
Publication statusPublished - 2012

Keywords

  • CD133
  • colon cancer

Fingerprint

Dive into the research topics of 'Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients'. Together they form a unique fingerprint.

Cite this